Shockwave C2 Aero Delivers. Our next-gen Coronary IVL device is engineered based on your feedback — and is ready to help you safely and effectively crack calcium with our proven mechanism of action (MOA).
Christopher L. Brown, MD, describes his early experience with Shockwave C2 Aero plus a recent case, highlighting improved deliverability, better rewrap, and greater flexibility in treating complex calcified multivessel coronary disease.
Christopher L. Brown, MD, describes his early experience with Shockwave C2 Aero plus a recent case, highlighting improved deliverability, better rewrap, and greater flexibility in treating complex calcified multivessel coronary disease.
Introducing Shockwave C2 Aero, the latest Aero-volution in coronary calcium modification. Watch this video to see some of the exciting features of this new design, which offers improved deliverability, a more compact rewrap, and more.
Introducing Shockwave C2 Aero, the latest Aero-volution in coronary calcium modification. Watch this video to see some of the exciting features of this new design, which offers improved deliverability, a more compact rewrap, and more.
Yousif Ahmad, MBBS, PhD, FACC, FSCAI, and Brett Wanamaker, MD, FACC, FSCAI, share their feedback after use of Shockwave C2 Aero, describing the technology, sharing two cases, and explaining how they will incorporate it into their practice.
Yousif Ahmad, MBBS, PhD, FACC, FSCAI, and Brett Wanamaker, MD, FACC, FSCAI, share their feedback after use of Shockwave C2 Aero, describing the technology, sharing two cases, and explaining how they will incorporate it into their practice.
Christopher L. Brown, MD, describes his early experience with Shockwave C2 Aero plus a recent case, highlighting improved deliverability, better rewrap, and greater flexibility in treating complex calcified multivessel coronary disease.
Christopher L. Brown, MD, describes his early experience with Shockwave C2 Aero plus a recent case, highlighting improved deliverability, better rewrap, and greater flexibility in treating complex calcified multivessel coronary disease.
Jorge A. Miranda, MD; M. Laiq Raja, MD, FACC, FSCAI
The Rotarex™ Catheter System can help treat acute and subacute limb ischemia, in-stent restenosis, and mixed-morphology PAD lesions while supporting efficient, IVUS-guided revascularization.
The Rotarex™ Catheter System can help treat acute and subacute limb ischemia, in-stent restenosis, and mixed-morphology PAD lesions while supporting efficient, IVUS-guided revascularization.
Dhananjay Chatterjee, MD, explains how the Makoto™ Intravascular Imaging System with DualPro helps reveal plaque burden, calcium, and vulnerable lesions beyond angiography alone to better inform PCI strategy and optimization.
Dhananjay Chatterjee, MD, explains how the Makoto™ Intravascular Imaging System with DualPro helps reveal plaque burden, calcium, and vulnerable lesions beyond angiography alone to better inform PCI strategy and optimization.
"STEMI: The Stakes": A video presentation by Sameer Mehta, MD, at the March 8th Nurse & Technologist Symposium at CRT 2026, held March 7-10 in Washington, D.C.
"STEMI: The Stakes": A video presentation by Sameer Mehta, MD, at the March 8th Nurse & Technologist Symposium at CRT 2026, held March 7-10 in Washington, D.C.
Introducing Shockwave C2 Aero, the latest Aero-volution in coronary calcium modification. Watch this video to see some of the exciting features of this new design, which offers improved deliverability, a more compact rewrap, and more.
Introducing Shockwave C2 Aero, the latest Aero-volution in coronary calcium modification. Watch this video to see some of the exciting features of this new design, which offers improved deliverability, a more compact rewrap, and more.
Yousif Ahmad, MBBS, PhD, FACC, FSCAI, and Brett Wanamaker, MD, FACC, FSCAI, share their feedback after use of Shockwave C2 Aero, describing the technology, sharing two cases, and explaining how they will incorporate it into their practice.
Yousif Ahmad, MBBS, PhD, FACC, FSCAI, and Brett Wanamaker, MD, FACC, FSCAI, share their feedback after use of Shockwave C2 Aero, describing the technology, sharing two cases, and explaining how they will incorporate it into their practice.
Brian C. Case, MD; Bailey Ann Richardson, MSN, AGNP, RN-BC, RNFA, CNOR, RCIS
Bailey Richardson, MSN, speaks with Brian Case, MD, about coronary microvascular dysfunction and why “normal” angiography can miss the cause of symptoms in patients with angina with non-obstructive coronary arteries (ANOCA).
Bailey Richardson, MSN, speaks with Brian Case, MD, about coronary microvascular dysfunction and why “normal” angiography can miss the cause of symptoms in patients with angina with non-obstructive coronary arteries (ANOCA).
In this 29-minute video (chapters available), Matthew H. Gonzalez, MD, discusses how pulmonary artery pressure monitoring with the CardioMEMS™ HF System made by Abbott shifts management from reactive to proactive by detecting hemodynamic...
In this 29-minute video (chapters available), Matthew H. Gonzalez, MD, discusses how pulmonary artery pressure monitoring with the CardioMEMS™ HF System made by Abbott shifts management from reactive to proactive by detecting hemodynamic...
Dr. Tanvir Bajwa highlights how the Stedi Extra Support Guidewire from Medtronic is designed to improve tracking, stability, and coaxial deployment during TAVR, and shares early experience suggesting it can support more predictable implant...
Dr. Tanvir Bajwa highlights how the Stedi Extra Support Guidewire from Medtronic is designed to improve tracking, stability, and coaxial deployment during TAVR, and shares early experience suggesting it can support more predictable implant...
Market tends are showing that more procedures are moving to out-of-hospital care settings, such as ambulatory surgery centers (ASCs) and office-based labs (OBLs) due to financial and operational benefits to the healthcare system and desire to...
Market tends are showing that more procedures are moving to out-of-hospital care settings, such as ambulatory surgery centers (ASCs) and office-based labs (OBLs) due to financial and operational benefits to the healthcare system and desire to...
“Shockwave C2 Aero makes it easier to navigate tortuous coronary anatomy without relying on additional upfront ancillary devices," said Margaret McEntegart, MD, PhD.
“Shockwave C2 Aero makes it easier to navigate tortuous coronary anatomy without relying on additional upfront ancillary devices," said Margaret McEntegart, MD, PhD.
“This early feasibility study for J-Valve is encouraging," said Dean J. Kereiakes, MD, MSCAI. "It shows that a dedicated device designed for aortic regurgitation can achieve sustained valve performance, meaningful symptom improvement, and...
“This early feasibility study for J-Valve is encouraging," said Dean J. Kereiakes, MD, MSCAI. "It shows that a dedicated device designed for aortic regurgitation can achieve sustained valve performance, meaningful symptom improvement, and...
A pacemaker without a box under the skin. Without wires to the heart. And without a battery that needs to be replaced every 7-10 years. It sounds like something from the distant future, but Dutch researchers at biotech company PacingCure have...
A pacemaker without a box under the skin. Without wires to the heart. And without a battery that needs to be replaced every 7-10 years. It sounds like something from the distant future, but Dutch researchers at biotech company PacingCure have...
The U.S. IDE study program will evaluate the purpose-built Shockwave™ SkyRunner Carotid IVL System designed to address the challenges of calcification in carotid arteries prior to stenting.
The U.S. IDE study program will evaluate the purpose-built Shockwave™ SkyRunner Carotid IVL System designed to address the challenges of calcification in carotid arteries prior to stenting.
ARLINGTON, VA — The Society of Cardiovascular Computed Tomography (SCCT) selected Ido Avivi, MD as the second recipient of the Chinnaiyan Catalyst Award for Women's Cardiovascular Health Research.
The award — established in 2025 by SCCT...
ARLINGTON, VA — The Society of Cardiovascular Computed Tomography (SCCT) selected Ido Avivi, MD as the second recipient of the Chinnaiyan Catalyst Award for Women's Cardiovascular Health Research.
The award — established in 2025 by SCCT...
Junkosha, pioneers of sophisticated fluoropolymer application technologies, has concluded its highly successful third Technology Innovator of the Year Award through a live stream YouTube ceremony held on June 17th 2026. Up first was Dr....
Junkosha, pioneers of sophisticated fluoropolymer application technologies, has concluded its highly successful third Technology Innovator of the Year Award through a live stream YouTube ceremony held on June 17th 2026. Up first was Dr....
Key Highlights
The Volante Steerable Guiding Sheath is designed to facilitate intracardiac, renal and peripheral placement of diagnostic and therapeutic devices.
With five different lengths and six different French sizes,...
Key Highlights
The Volante Steerable Guiding Sheath is designed to facilitate intracardiac, renal and peripheral placement of diagnostic and therapeutic devices.
With five different lengths and six different French sizes,...
Treating patients within 12 hours of diagnosis may be associated with greater improvement in acute hemodynamic and right ventricle measures compared to treatment after 12 hours, with similar safety outcomes between groups.
Treating patients within 12 hours of diagnosis may be associated with greater improvement in acute hemodynamic and right ventricle measures compared to treatment after 12 hours, with similar safety outcomes between groups.
The most notable enhancement is the ability to view medical images directly within the app. This long-awaited feature enables care teams to review imaging in real time.
The most notable enhancement is the ability to view medical images directly within the app. This long-awaited feature enables care teams to review imaging in real time.
AK-AVS, which received FDA Breakthrough Device Designation in October 2024, is an ECG-based AI algorithm intended to aid in the diagnosis of moderate to severe aortic valve stenosis in adult patients 22 years and older, utilizing data derived...
AK-AVS, which received FDA Breakthrough Device Designation in October 2024, is an ECG-based AI algorithm intended to aid in the diagnosis of moderate to severe aortic valve stenosis in adult patients 22 years and older, utilizing data derived...
AK-AVS, which received FDA...
06/16/2026
Cath Lab Digest
About Shockwave
Shockwave IVL pioneers innovative technologies that help improve lives around the globe. The Shockwave IVL system is transforming standards of care and driving better outcomes for underserved patients. Shockwave IVL: In the U.S.: Rx only. Prior to use, please reference the Important Safety Information for more information on indications, contraindications, warnings, precautions and adverse events.
